EC
EVH icon

EntryPoint Capital’s Evolent Health EVH Stock Holding History

EntryPoint Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-825
Closed -$27.3K – 1524
2023
Q4 		$27.3K Buy
+825
New +$23.3K 0.03% 953

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EntryPoint Capital's EVH Position: Q1 2024 in Review

EntryPoint Capital sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 825 shares — an estimated $27.3K sold.

EntryPoint Capital first reported a position in EVH in Q4 2023 and held it in 1 quarter. The position peaked at $27.3K in Q4 2023. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

  • EntryPoint Capital reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
  • EntryPoint Capital sold 825 Evolent Health shares in Q1 2024, an estimated $27.3K.
  • EntryPoint Capital first reported a position in Evolent Health in Q4 2023 and held it in 1 quarter.
  • EntryPoint Capital's Evolent Health position peaked at $27.3K in Q4 2023.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.